Advertisement
MNOV vs TIL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOV is a Hold and TIL is a Hold.
MNOV's RSI Indicator ascending out of oversold territory
The RSI Oscillator for MNOV moved out of oversold territory on October 21, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 26 of the 32 cases the stock moved higher. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 72 cases where MNOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for MNOV just turned positive on October 28, 2026. Looking at past instances where MNOV's MACD turned positive, the stock continued to rise in 40 of 52 cases over the following month. The odds of a continued upward trend are 77%.
Following a +1.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNOV advanced for three days, in 129 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNOV as a result. In 76 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
MNOV moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MNOV crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for MNOV entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.928) is normal, around the industry mean (3.498). P/E Ratio (-6.952) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (135.135) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. MNOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
TIL in downward trend: price dove below 50-day moving average on November 06, 2026
TIL moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend. In 40 of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 46 cases where TIL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TIL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for TIL entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TIL's RSI Indicator exited the oversold zone, 32 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on TIL as a result. In 69 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for TIL just turned positive on October 28, 2026. Looking at past instances where TIL's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
Following a +6.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where TIL advanced for three days, in 191 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
TIL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.431) is normal, around the industry mean (3.498). P/E Ratio (-1.552) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. TIL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TIL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
MNOV | TIL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 21 Undervalued | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 96 | |
PRICE GROWTH RATING 1..100 | 49 | 73 | |
P/E GROWTH RATING 1..100 | 57 | 37 | |
SEASONALITY SCORE 1..100 | 50 | 81 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MNOV's Valuation (21) in the Biotechnology industry is in the same range as TIL (32) in the Precious Metals industry. This means that MNOV’s stock grew similarly to TIL’s over the last 12 months.
MNOV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TIL (100) in the Precious Metals industry. This means that MNOV’s stock grew similarly to TIL’s over the last 12 months.
MNOV's SMR Rating (96) in the Biotechnology industry is in the same range as TIL (96) in the Precious Metals industry. This means that MNOV’s stock grew similarly to TIL’s over the last 12 months.
MNOV's Price Growth Rating (49) in the Biotechnology industry is in the same range as TIL (73) in the Precious Metals industry. This means that MNOV’s stock grew similarly to TIL’s over the last 12 months.
TIL's P/E Growth Rating (37) in the Precious Metals industry is in the same range as MNOV (57) in the Biotechnology industry. This means that TIL’s stock grew similarly to MNOV’s over the last 12 months.
| MNOV | TIL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 87% |
| Advances ODDS (%) | 3 days ago 67% | 8 days ago 78% |
| Declines ODDS (%) | 23 days ago 79% | 2 days ago 86% |
| BollingerBands ODDS (%) | N/A | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 81% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MNOV’s FA Score shows that 1 FA rating(s) are green while TIL’s FA Score has 1 green FA rating(s).
- MNOV’s FA Score: 1 green, 4 red.
- TIL’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MNOV’s TA Score shows that 4 TA indicator(s) are bullish while TIL’s TA Score has 5 bullish TA indicator(s).
- MNOV’s TA Score: 4 bullish, 5 bearish.
- TIL’s TA Score: 5 bullish, 4 bearish.
Price Growth
MNOV (@Biotechnology) experienced а -1.41% price change this week, while TIL (@Biotechnology) price change was -4.80% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
MNOV is expected to report earnings on Nov 11, 2026.
TIL is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
MNOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.
| Ticker / NAME | Correlation To MNOV | 1D Price Change % | ||
|---|---|---|---|---|
| MNOV | 100% | -4.76% | ||
| FATE - MNOV | 36% Loosely correlated | -8.76% | ||
| NCEL - MNOV | 36% Loosely correlated | +4.00% | ||
| VIR - MNOV | 29% Poorly correlated | -3.63% | ||
| IMA - MNOV | 28% Poorly correlated | -4.03% | ||
| TIL - MNOV | 28% Poorly correlated | -1.85% | ||
More | ||||
TIL and
Correlation & Price change
A.I.dvisor indicates that over the last year, TIL has been loosely correlated with ZNTL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TIL jumps, then ZNTL could also see price increases.
| Ticker / NAME | Correlation To TIL | 1D Price Change % | ||
|---|---|---|---|---|
| TIL | 100% | -1.85% | ||
| ZNTL - TIL | 35% Loosely correlated | +3.45% | ||
| GYRE - TIL | 29% Poorly correlated | -9.03% | ||
| ABCL - TIL | 29% Poorly correlated | -0.32% | ||
| RZLT - TIL | 29% Poorly correlated | +4.09% | ||
| MNOV - TIL | 29% Poorly correlated | -4.76% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AHYB | 44.72 | -0.18 | -0.40% |
| American Century Select High Yield ETF (AHYB) | |||
| VIOG | 142.42 | -0.66 | -0.46% |
| Vanguard S&P Small-Cap 600 Growth ETF (VIOG) | |||
| NUW | 13.76 | -0.20 | -1.43% |
| Nuveen AMT-Free Municipal Value Fund | |||
| CRMG | 6.55 | -0.10 | -1.50% |
| Leverage Shares 2X Long CRM Daily ETF (CRMG) | |||
| PFH | 15.04 | -0.42 | -2.72% |
| Prudential Financial | |||